@article{6683da72a362473ebc03ef9fc0701fea,
title = "Omalizumab safety in pregnancy",
keywords = "Omalizumab, drug safety, fetal malformations, placental transfer, pregnancy, preterm delivery, thrombocytopenia",
author = "Francesca Levi-Schaffer and David Mankuta",
note = "Funding Information: We acknowledge the assistance of Fidan Rahimli Alekberli, MD, in discussions of the manuscript and the literature search. Dr Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center at the Hebrew University. F.L.-S.{\textquoteright}s research is funded partly by the Israel Science Foundation, Rosetrees Trust (United Kingdom), Aimwell Charitable Trust (United Kingdom), the United States–Israel Binational Science Foundation (BSF), and the Israel Ministry of Science and Technology.",
year = "2020",
month = feb,
doi = "https://doi.org/10.1016/j.jaci.2019.11.018",
language = "الإنجليزيّة",
volume = "145",
pages = "481--483",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "American Academy of Allergy, Asthma and Immunology",
number = "2",
}